“Inhibition of Toll-Like Receptor-4 Expression for Amelioration of Myocardial Injury in Diabetes: A Meta-Analysis”. 2022. Clinics 77 (November): 100137. https://doi.org/10.1016/j.clinsp.2022.100137.